GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:002260412 | Liver | Cirrhotic | regulation of cell morphogenesis | 127/4634 | 309/18723 | 1.45e-10 | 7.44e-09 | 127 |
GO:004424212 | Liver | Cirrhotic | cellular lipid catabolic process | 82/4634 | 214/18723 | 6.91e-06 | 1.08e-04 | 82 |
GO:001604212 | Liver | Cirrhotic | lipid catabolic process | 112/4634 | 320/18723 | 2.31e-05 | 3.03e-04 | 112 |
GO:009758111 | Liver | Cirrhotic | lamellipodium organization | 40/4634 | 90/18723 | 3.48e-05 | 4.26e-04 | 40 |
GO:190274511 | Liver | Cirrhotic | positive regulation of lamellipodium organization | 19/4634 | 37/18723 | 4.39e-04 | 3.57e-03 | 19 |
GO:190274311 | Liver | Cirrhotic | regulation of lamellipodium organization | 25/4634 | 54/18723 | 4.63e-04 | 3.75e-03 | 25 |
GO:0006643 | Liver | Cirrhotic | membrane lipid metabolic process | 69/4634 | 203/18723 | 1.89e-03 | 1.19e-02 | 69 |
GO:000166712 | Liver | Cirrhotic | ameboidal-type cell migration | 145/4634 | 475/18723 | 2.23e-03 | 1.36e-02 | 145 |
GO:00106327 | Liver | Cirrhotic | regulation of epithelial cell migration | 93/4634 | 292/18723 | 3.46e-03 | 1.92e-02 | 93 |
GO:00106317 | Liver | Cirrhotic | epithelial cell migration | 110/4634 | 357/18723 | 5.14e-03 | 2.65e-02 | 110 |
GO:00901327 | Liver | Cirrhotic | epithelium migration | 110/4634 | 360/18723 | 6.79e-03 | 3.35e-02 | 110 |
GO:00901307 | Liver | Cirrhotic | tissue migration | 111/4634 | 365/18723 | 7.66e-03 | 3.61e-02 | 111 |
GO:00464341 | Liver | Cirrhotic | organophosphate catabolic process | 52/4634 | 155/18723 | 8.42e-03 | 3.91e-02 | 52 |
GO:00106346 | Liver | Cirrhotic | positive regulation of epithelial cell migration | 58/4634 | 176/18723 | 8.54e-03 | 3.96e-02 | 58 |
GO:002260422 | Liver | HCC | regulation of cell morphogenesis | 188/7958 | 309/18723 | 4.84e-11 | 1.82e-09 | 188 |
GO:004424222 | Liver | HCC | cellular lipid catabolic process | 134/7958 | 214/18723 | 2.07e-09 | 5.79e-08 | 134 |
GO:00066444 | Liver | HCC | phospholipid metabolic process | 214/7958 | 383/18723 | 7.25e-08 | 1.48e-06 | 214 |
GO:0090305 | Liver | HCC | nucleic acid phosphodiester bond hydrolysis | 152/7958 | 261/18723 | 1.90e-07 | 3.46e-06 | 152 |
GO:004648611 | Liver | HCC | glycerolipid metabolic process | 215/7958 | 392/18723 | 4.54e-07 | 7.49e-06 | 215 |
GO:003134611 | Liver | HCC | positive regulation of cell projection organization | 193/7958 | 353/18723 | 2.28e-06 | 3.08e-05 | 193 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ENPP2 | SNV | Missense_Mutation | novel | c.2137N>A | p.Pro713Thr | p.P713T | Q13822 | protein_coding | tolerated(0.21) | benign(0.076) | TCGA-L4-A4E5-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | | c.1243N>A | p.Glu415Lys | p.E415K | Q13822 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-18-3409-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
ENPP2 | SNV | Missense_Mutation | | c.728N>G | p.His243Arg | p.H243R | Q13822 | protein_coding | deleterious(0.03) | benign(0.001) | TCGA-22-5472-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | PD |
ENPP2 | SNV | Missense_Mutation | | c.1231N>A | p.Asp411Asn | p.D411N | Q13822 | protein_coding | deleterious(0) | probably_damaging(0.937) | TCGA-37-5819-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | novel | c.1512N>T | p.Trp504Cys | p.W504C | Q13822 | protein_coding | deleterious(0.01) | probably_damaging(0.973) | TCGA-39-5011-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Chemotherapy | taxol | SD |
ENPP2 | SNV | Missense_Mutation | | c.377N>G | p.Ala126Gly | p.A126G | Q13822 | protein_coding | tolerated(0.09) | benign(0.036) | TCGA-46-6026-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | SD |
ENPP2 | SNV | Missense_Mutation | novel | c.1688N>T | p.Asn563Ile | p.N563I | Q13822 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-56-A4ZJ-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | novel | c.790N>C | p.Ala264Pro | p.A264P | Q13822 | protein_coding | deleterious(0) | probably_damaging(0.964) | TCGA-58-8390-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | | c.664N>C | p.Tyr222His | p.Y222H | Q13822 | protein_coding | deleterious(0.03) | probably_damaging(0.982) | TCGA-60-2726-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ENPP2 | SNV | Missense_Mutation | novel | c.1126N>G | p.Lys376Glu | p.K376E | Q13822 | protein_coding | tolerated(1) | probably_damaging(0.987) | TCGA-66-2787-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 315661229 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-12188 | CHEMBL1089321 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | (S)-CARBA CYCLIC-PHOSPHATIDIC ACID | CHEMBL1630084 | 21051230 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-1741 | CHEMBL483302 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 354702264 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 315661228 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-34937 | CHEMBL1092743 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | | NSC-1698 | CHEMBL1093490 | 20349977 |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 315661227 | | |
5168 | ENPP2 | ENZYME, DRUGGABLE GENOME, TRANSCRIPTION FACTOR BINDING | inhibitor | 336446947 | ZIRITAXESTAT | |